BACKGROUND: Incidence rates of pediatric cancers in the United States are typically reported in 5-year age groups, obscuring variation by single year of age. Additionally, racial and ethnic variation in incidence is typically presented in broad categories rather than by narrow age ranges. METHODS: The Surveillance, Epidemiology, and End Results (SEER) 18 data (2000-2017) were examined to calculate frequencies and age-adjusted incidence rates among individuals aged birth to 39 years. Incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) were estimated as the measure of association for rate comparisons by race and Hispanic origin overall and by single year of age. RESULTS: Several histologic types showed substantial variation in race/ethnicity-specific and overall rates by single year of age. Overall, Black children and young adults experienced substantially decreased incidence of acute lymphoid leukemia (IRR, 0.52; 95% CI, 0.49-0.55) compared to Whites, and this decreased incidence was strongest at ages 1 through 7 years and 16 through 20 years. Hispanic individuals experienced decreased overall incidence of Hodgkin lymphoma (IRR, 0.50; 95% CI, 0.48-0.52) and astrocytoma (IRR, 0.54; 95% CI, 0.52-0.56) and increased risk of acute lymphoblastic leukemia (IRR, 1.46; 95% CI, 1.42-1.51) compared to non-Hispanic Whites, and the increased risk was strongest at ages 10 through 23 years. Substantial decreased risk across many tumor types was also observed for Asian/Pacific Islanders and American Indian/Alaska Natives. CONCLUSIONS: Examination of incidence rates for pediatric cancers by narrow age groups may provide insights regarding etiological differences in subgroups. Additionally, variation in age-specific incidence rates by race and ethnicity may enable hypothesis generation on drivers of disparities observed.
BACKGROUND: Incidence rates of pediatric cancers in the United States are typically reported in 5-year age groups, obscuring variation by single year of age. Additionally, racial and ethnic variation in incidence is typically presented in broad categories rather than by narrow age ranges. METHODS: The Surveillance, Epidemiology, and End Results (SEER) 18 data (2000-2017) were examined to calculate frequencies and age-adjusted incidence rates among individuals aged birth to 39 years. Incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) were estimated as the measure of association for rate comparisons by race and Hispanic origin overall and by single year of age. RESULTS: Several histologic types showed substantial variation in race/ethnicity-specific and overall rates by single year of age. Overall, Black children and young adults experienced substantially decreased incidence of acute lymphoid leukemia (IRR, 0.52; 95% CI, 0.49-0.55) compared to Whites, and this decreased incidence was strongest at ages 1 through 7 years and 16 through 20 years. Hispanic individuals experienced decreased overall incidence of Hodgkin lymphoma (IRR, 0.50; 95% CI, 0.48-0.52) and astrocytoma (IRR, 0.54; 95% CI, 0.52-0.56) and increased risk of acute lymphoblastic leukemia (IRR, 1.46; 95% CI, 1.42-1.51) compared to non-Hispanic Whites, and the increased risk was strongest at ages 10 through 23 years. Substantial decreased risk across many tumor types was also observed for Asian/Pacific Islanders and American Indian/Alaska Natives. CONCLUSIONS: Examination of incidence rates for pediatric cancers by narrow age groups may provide insights regarding etiological differences in subgroups. Additionally, variation in age-specific incidence rates by race and ethnicity may enable hypothesis generation on drivers of disparities observed.
Authors: Logan G Spector; Andrew T DeWan; Nathan D Pankratz; Lucie M Turcotte; Jun J Yang; Michael E Scheurer Journal: Am J Epidemiol Date: 2019-06-01 Impact factor: 4.897
Authors: Yohann Nédélec; Joaquín Sanz; Golshid Baharian; Zachary A Szpiech; Alain Pacis; Anne Dumaine; Jean-Christophe Grenier; Andrew Freiman; Aaron J Sams; Steven Hebert; Ariane Pagé Sabourin; Francesca Luca; Ran Blekhman; Ryan D Hernandez; Roger Pique-Regi; Jenny Tung; Vania Yotova; Luis B Barreiro Journal: Cell Date: 2016-10-20 Impact factor: 41.582
Authors: Elizabeth Ward; Carol DeSantis; Anthony Robbins; Betsy Kohler; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2014-01-31 Impact factor: 508.702
Authors: Melinda C Aldrich; Luoping Zhang; Joseph L Wiemels; Xiaomei Ma; Mignon L Loh; Catherine Metayer; Steve Selvin; James Feusner; Martyn T Smith; Patricia A Buffler Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-03 Impact factor: 4.254
Authors: Jayaram Vijayakrishnan; Maoxiang Qian; James B Studd; Wenjian Yang; Ben Kinnersley; Philip J Law; Peter Broderick; Elizabeth A Raetz; James Allan; Ching-Hon Pui; Ajay Vora; William E Evans; Anthony Moorman; Allen Yeoh; Wentao Yang; Chunliang Li; Claus R Bartram; Charles G Mullighan; Martin Zimmerman; Stephen P Hunger; Martin Schrappe; Mary V Relling; Martin Stanulla; Mignon L Loh; Richard S Houlston; Jun J Yang Journal: Nat Commun Date: 2019-11-25 Impact factor: 14.919
Authors: Austin L Brown; Pagna Sok; Michael E Scheurer; Karen R Rabin; Erin L Marcotte; Douglas S Hawkins; Logan G Spector; Philip J Lupo Journal: Cancer Date: 2022-04-28 Impact factor: 6.921
Authors: Lori Muffly; Jun Yin; Sawyer Jacobson; Anna Wall; Elisa Quiroz; Anjali S Advani; Selina M Luger; Martin S Tallman; Mark R Litzow; Matthew C Foster; Harry P Erba; Frederick R Appelbaum; Richard A Larson; Theresa H M Keegan; Wendy Stock Journal: Blood Adv Date: 2022-07-26